Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease.
Yanai H, Adachi H, Hakoshima M, Katsuyama H.
Int J Mol Sci. 2021 Aug 26;22(17):9221. doi: 10.3390/ijms22179221.
Hyperuricemia and Cardiovascular Disease.
Zhang S, Wang Y, Cheng J, Huangfu N, Zhao R, Xu Z, Zhang F, Zheng W, Zhang D.
Curr Pharm Des. 2019;25(6):700-709. doi: 10.2174/1381612825666190408122557.
Fuling-Zexie formula attenuates hyperuricemia-induced nephropathy and inhibits JAK2/STAT3 signaling and NLRP3 inflammasome activation in mice.
Lu M, Yin J, Xu T, Dai X, Liu T, Zhang Y, Wang S, Liu Y, Shi H, Zhang Y, Mo F, Sukhorukov V, Orekhov AN, Gao S, Wang L, Zhang D.
J Ethnopharmacol. 2024 Jan 30;319(Pt 2):117262. doi: 10.1016/j.jep.2023.117262. Epub 2023 Oct 1.
Hyperuricemia aggravates the progression of IgA nephropathy.
Geng YH, Zhang Z, Zhang JJ, Huang B, Guo ZS, Wang XT, Zhang LQ, Quan SX, Hu RM, Liu YF.
Int Urol Nephrol. 2022 Sep;54(9):2227-2237. doi: 10.1007/s11255-022-03125-4. Epub 2022 Jan 24.
Research Advances in the Mechanisms of Hyperuricemia-Induced Renal Injury.
Su HY, Yang C, Liang D, Liu HF.
Biomed Res Int. 2020 Jun 26;2020:5817348. doi: 10.1155/2020/5817348. eCollection 2020.
Hyperuricemia, the heart, and the kidneys - to treat or not to treat?
Petreski T, Ekart R, Hojs R, Bevc S.
Ren Fail. 2020 Nov;42(1):978-986. doi: 10.1080/0886022X.2020.1822185.
Role of asymptomatic hyperuricemia in the progression of chronic kidney disease and cardiovascular disease.
Waheed Y, Yang F, Sun D.
Korean J Intern Med. 2021 Nov;36(6):1281-1293. doi: 10.3904/kjim.2020.340. Epub 2021 Jul 8.
Vitamin C alleviates hyperuricemia nephropathy by reducing inflammation and fibrosis.
Li H, Liu X, Lee MH, Li H.
J Food Sci. 2021 Jul;86(7):3265-3276. doi: 10.1111/1750-3841.15803. Epub 2021 Jun 23.
The SGLT2 inhibitor dapagliflozin ameliorates renal fibrosis in hyperuricemic nephropathy.
Hu H, Li W, Hao Y, Peng Z, Zou Z, Wei J, Zhou Y, Liang W, Cao Y.
Cell Rep Med. 2024 Aug 20;5(8):101690. doi: 10.1016/j.xcrm.2024.101690.
Coptisine protects against hyperuricemic nephropathy through alleviating inflammation, oxidative stress and mitochondrial apoptosis via PI3K/Akt signaling pathway.
Liu Y, Gong S, Li K, Wu G, Zheng X, Zheng J, Lu X, Zhang L, Li J, Su Z, Liu Y, Xie J, Chen J, Li Y.
Biomed Pharmacother. 2022 Dec;156:113941. doi: 10.1016/j.biopha.2022.113941. Epub 2022 Nov 2.
